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Regulatory T cells (Tregs) have a central role in maintaining immune homoeostasis through 
various mechanisms. Although the Forkhead transcription factor Foxp3 defines the Treg cell 
lineage and functions, the molecular mechanisms of Foxp3 induction and maintenance remain 
elusive. Here we show that Foxp3 is one of the direct targets of nr4a2. nr4a2 binds to regulatory 
regions of Foxp3, where it mediates permissive histone modifications. Ectopic expression of 
nr4a2 imparts Treg-like suppressive activity to naïve CD4 +  T cells by inducing Foxp3 and by 
repressing cytokine production, including interferon-γ and interleukin-2. Deletion of nr4a2 
in T cells attenuates induction of Tregs and causes aberrant induction of Th1, leading to the 
exacerbation of colitis. nr4a2-deficeint Tregs are prone to lose Foxp3 expression and have 
attenuated suppressive ability both in vitro and in vivo. Thus, nr4a2 has the ability to maintain 
T-cell homoeostasis by regulating induction, maintenance and suppressor functions of Tregs, 
and by repression of aberrant Th1 induction. 
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R
egulatory  T  cells  (Tregs),  which  are  characterized  by  the 
expression of Foxp3, have indispensable roles in immuno-
logical tolerance, protecting the host from autoimmune dis-
eases and allergies1. Foxp3 is specifically expressed in Tregs and 
plays a critical role in the differentiation, maintenance and effector 
functions of Tregs2. The presence of Foxp3 in Tregs is essential, as 
demonstrated by the fatal autoimmune disorders that occur in both 
humans and mice with Foxp3 gene inactivation3,4. Foxp3 is also suf-
ficient to confer Treg-like suppressive activity on ectopic expression 
in non-Tregs5. Foxp3 is transiently induced by transforming growth 
factor (TGF)-β in naïve T cells, which are called induced Tregs 
(iTregs)6, whereas thymus-derived Tregs are called nTregs (natural 
occurring Tregs). We recently demonstrated that Smad2 and Smad3 
are redundantly essential for the induction of Foxp3 in iTregs7.
The  mechanisms  underlying  Foxp3  expression  have  been   
extensively analysed. For Foxp3 regulation, a proximal promoter 
and  three  intronic  enhancers,  designated  conserved  noncoding   
sequences (CNSs) 1, 2 and 3, have been identified. The proximal 
promoter has potential binding sites for transcription factors includ-
ing c-Rel and FoxO8,9. CNS1, which has binding sites for Smads and   
NF-AT, is critical for iTreg induction10,11. CNS2 contains a hypo-
methylated CpG island, which is essential for Foxp3 maintenance, 
and binding sites for Stat5, Runx/CBFβ, FoxO and c-Rel as well as 
Foxp3 itself 11–14. CNS3 binds to c-Rel and is important for the initia-
tion of Foxp3 expression8,11. Among the enhancer-interacting fac-
tors that have been identified, very few have been analysed in terms 
of their direct effect on epigenetic modification, because the ectopic 
expression of each factor triggers insufficient induction of Foxp3.
Nr4a2 belongs to the Nr4a family of transcription factors, and 
exhibits a high similarity to the other two members, Nr4a1 and 
Nr4a3, especially in its DNA-binding domain (~91–95% identity). 
Although Nr4a belongs to the nuclear receptors superfamily, their 
activity is not considered to be regulated by ligands, because their 
ligand-binding pockets are hidden by bulky amino acids, and their 
ligand-binding domains are constitutively active15. Thus, their func-
tions are assumed to be regulated largely at the expression level, 
although various post-translational modifications have also been 
reported  to  modulate  their  functions16,17.  The  Nr4a  family  has 
important roles in various physiological and pathological events18–21.   
Several  disorders  are  associated  with  the  dysfunction  of  Nr4a, 
including metabolic syndromes and Parkinson’s disease18,19.
In this study, we demonstrated that ectopic expression of Nr4a2 
in naïve CD4 +  T cells along with T-cell receptor (TCR) stimulation 
was sufficient for the induction of Foxp3 and for the suppression of 
effector cytokine production, imparting Treg-like suppressive activ-
ity to naïve T cells. Through further analysis with Nr4a2-deficient 
animals and cells, we revealed that Nr4a2 was crucial in regulating 
the Th1/Treg balance, Treg lineage maintenance and effector func-
tions of Tregs, contributing to immune homoeostasis.
Results
Ectopic expression of Nr4a2 induces Foxp3. To isolate the genes 
relevant  to  Treg  induction,  especially  in  the  thymus,  we  first 
examined the ‘Treg signature genes,’ which were categorized into 
seven clusters according to their dependence on Foxp3, TGF-β, 
TCR stimulation and interleukin (IL)-2 for their expression22. We 
were interested in one cluster, designated ‘cluster 6’ by Hill et al.22; 
the genes are enriched in Tregs, but their expression is independent 
of  TGF-β  or  Foxp3  transduction.  These  genes  are  predicted  to 
induce Foxp3. We isolated transcription factors in cluster 6 and 
investigated  their  ability  to  transactivate  the  Foxp3-luciferase 
reporter construct23 (Supplementary Fig. S1). Among these, Nr4a2 
had the strongest potential to activate the Foxp3 promoter.
We confirmed that the expression levels of Nr4a2 were higher 
in Foxp3 +  Tregs than in Foxp3 −  T cells at both the protein and 
mRNA levels (Fig. 1a). Nr4a2 was low in naïve T cells, but was 
transiently  induced  by  TCR  stimulation  (Fig.  1b).  Nr4a2  was 
undetectable in Th1, Th2, Th17 or iTreg cells differentiated in vitro 
(Supplementary Fig. S2).
Next, we investigated the ability of Nr4a2 to induce Foxp3. We 
ectopically  expressed  Nr4a2  in  mouse  CD4-single-positive  (SP) 
cells by retroviral transduction and measured Foxp3 expression. 
Foxp3  expression  was  monitored  using  cells  isolated  from  the 
knock-in mouse strain Foxp3-hCD2-hCD52-KI, in which human 
CD2 (hCD2) is coexpressed with Foxp3 (ref. 24), and can be moni-
tored by surface staining with anti-hCD2 antibodies. Nr4a2 strongly 
induced  Foxp3,  but  its  transactivation-deficient  mutant  did  not 
(Fig. 1c), despite its higher expression (Supplementary Fig. S3). This 
Nr4a2-mediated induction of Foxp3 was independent of TGF-β in 
the culture media, because inhibition of TGF-β signalling with neu-
tralizing antibodies25 or with a chemical inhibitor of TGF-β26 did 
not affect Foxp3 induction by Nr4a2, whereas these are effective in 
iTreg inhibition (Fig. 1d).
We searched for the Nr4a2-responsive element of the foxp3 
promoter/enhancer using a reporter assay. By constructing the 
deletion series of the promoter–reporters from the 5′ to 3′ direc-
tion (the 3′ border was fixed at  + 12), we found that the  − 209 
to  + 12 promoter region was the minimal responsive region to 
Nr4a2 (Fig. 1e). As for the binding sites for Nr4a, several sequences 
have recently been identified27, in addition to the canonical bind-
ing elements28–30. We found five potential Nr4a-binding elements 
between  − 209 and  + 12, and identified the most important ele-
ment between  − 209 and  − 175 (see e, f, h constructs in Fig. 1e and 
Supplementary  Fig.  S4).  Insertion  of  CNS1  enhanced  promoter 
activity twofold, although CNS2 did not (Fig. 1e). This observa-
tion was supported by ChIP analyis (Fig. 1f), wherein the strongest   
binding of Nr4a2 was to the proximal promoter, but did not to   
CNS3 in Tregs. Moderate binding was observed in CNS1, and weaker 
binding  was  observed  in  CNS2.  These  data  indicate  that  Nr4a2   
acts mainly on the proximal promoter and also weakly on CNS1.
Nr4a2  induces  epigenetic  modification  of  histones.  We  inves-
tigated the effect of Nr4a2 on the epigenetic status of the foxp3 
promoter/enhancer. First, we isolated the total green fluorescence 
protein  (GFP)-positive  fractions  from  Nr4a2-virus-  or  control-
virus-transduced CD4-SP cells, and performed native ChIP to com-
pare their histone modification status with those of Tregs and naïve 
CD4 +  T cells. As depicted in Figure 2a–c, Nr4a2 induced active 
histone modifications, histone H4-acetylation and histone H3K4-
trimethylation, similar to the patterns in Tregs. H3K27-trimeth-
ylation, a repressive histone modification was not detected in both 
Tregs and Nr4a2-transduced T cells.
Because the CpG island in the CNS2 is highly demethylated 
during Treg development, we investigated the effects of Nr4a2 on 
the CpG methylation status of this region. Bisulphite sequencing of 
Nr4a2-induced Foxp3 +  cells and Tregs revealed that Nr4a2 could 
not induce demethylation of CNS2 (Fig. 2d). The results of these 
epigenetic experiments suggest that Nr4a2 induces Foxp3 in CD4 +  
T cells by mediating active histone modifications.
Nr4a2 can induce Foxp3 and repress Th1 differentiation. Because 
Nr4a mediates various physiological events, some in a redundant 
manner and others in a non-redundant manner, we compared the 
ability of the three family members to induce Foxp3. Importantly, 
both Nr4a1 and Nr4a3 have also been reported to be abundant in 
Tregs31 and inducible by TCR stimulation32. We found that Nr4a1 
rarely induced Foxp3, whereas Nr4a3 did so to an intermediate 
degree (Fig. 3a,b), despite the expression levels of these proteins 
were similar (Supplementary Fig. S3a).
In  microglia,  Nr4a2  has  been  shown  to  repress  inflamma-
tory cytokines33. Therefore, we analysed the effects of Nr4a on the 
production of the Th1-effector cytokine interferon (IFN)-γ. Inter-ARTICLE     
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estingly,  Nr4a2  and  Nr4a3,  which  induced  Foxp3,  also  strongly 
repressed IFN-γ (Fig. 3a,c). Nr4a1, in contrast, could not repress 
IFN-γ. In microglia, Nr4a2 repressed cytokines in a DNA-binding-
independent manner33. However, the C280A/E281A mutant, which 
lacks the DNA-binding activity33, could no longer induce Foxp3 
or repress IFN-γ (Supplementary Fig. S3b), suggesting that Nr4a2 
must bind DNA directly, to execute both functions.
We further analysed Foxp3 and cytokine regulation by Nr4a2 
under Th1- and Th17-conditions. Both IFN-γ and IL-17 were signifi-
cantly repressed under Th1- and Th17-conditions, respectively, and 
Foxp3 was induced in both conditions by Nr4a2 (Fig. 3d). Impor-
tantly, the Nr4a2-mediated repression of IFN-γ occurred even in 
Foxp3-negative fractions, and the induced Foxp3 further repressed 
IFN-γ (Fig. 3e). In contrast, IL-17 repression was detected only in 
Nr4a2
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Figure 1 | Nr4a2 is highly expressed in Treg subsets and directly induces Foxp3. (a) Top: nr4a2 protein expression in Tregs (CD4 + CD25 + ) and in  
the Tconv (CD4 + CD25–) population. Bottom: quantitative PCR (qPCR) analysis of nr4a2 expression in CD4 +  T cell subsets, normalized against Hprt.  
(b) naïve T cells were incubated under TCR stimulation with anti-CD3, CD28 antibodies. The protein level at each indicated time point was analysed by 
western blotting. Bottom: qPCR results depict the induction of nr4a2 by TCR stimulation. Data are normalized against Hprt. (c) Effects of expression of 
nr4a2 (indicated by GFP expression, which is synergistically expressed by IREs in the emIGR1 vector) and its transactivation-deficient mutant nr4a2-∆n, 
which lacks the n terminus 237aa of the transactivation domain28, on Foxp3 expression emIGR1, an empty vector, was used as a negative control. Foxp3 
induction was detected with an anti-human CD2 (hCD2) antibody, which recognizes membranous hCD2 protein coexpressed with endogenous Foxp3 in 
the Foxp3-hCD2-hCD52-KI mice. numbers in FACs plots represent percentages of CD4 +  T cells in the gated area. (d) Effects of blocking TGF-β signalling 
with a chemical inhibitor (sB431542, at 5 or 20 µm) or TGF-β neutralizing antibodies, at 5 or 20 µg ml − 1 on TGF-β or nr4a2-mediated Foxp3 induction.  
(e) Foxp3 promoter and enhancer-driven luciferase reporter constructs were transfected into the 293 cell line. Regions with consensus binding sequences 
for nr4a are indicated by open ovals. (f) ChIP assay of nr4a2 in the Foxp3 promoter and enhancer regions in naive CD4 +  T cells and Tregs. Cell lysates 
were immunoprecipitated with anti-nr4a2 (open bars) or control IgG (filled bars). Values are presented as the percentage of corresponding input with the 
standard deviation (s.d.) of three independent experiments of triplicate. numbers in FACs plots represent percentages of CD4 + T cells in the gated area. 
Data shown in (a, b, d, e) are representative of three independent experiments (mean and s.d. of triplicate).ARTICLE
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the  Foxp3-positive  fraction  (Fig.  3e).  These  results  indicate  that 
Nr4a2 has the ability to repress Th1 differentiation by both Foxp3- 
independent and -dependent mechanisms.
We further investigated the differences between the Nr4a proteins 
at the molecular level through domain swapping analysis. When   
the amino (N) terminus of Nr4a3 was replaced with that of Nr4a2 
(Fig. 3f), the resulting chimeric construct affected transcriptional 
activity at a level equivalent to that of Nr4a2 (Fig. 3h). Importantly, 
the  chimeric  construct  also  exhibited  a  similar  level  of  Foxp3   
induction (Fig. 3g,i), indicating that the intrinsic transcriptional 
activity in the N terminus distinguishes Nr4a2 and Nr4a3. Similar 
domain swapping also imparted significant Foxp3 induction and 
IFN-γ repression ability to Nr4a1 (Supplementary Fig. S3c). How-
ever, the effects were not as strong as those of Nr4a2, indicating 
functions in carboxy terminus also distinguish Nr4a1 and Nr4a2.
Nr4a2-induced Foxp3 +  cells have in vitro suppression activity. 
Next,  we  characterized  Nr4a2-induced  Foxp3 +   cells  by  analys-
ing the expression profile of Treg effectors and suppression activ-
ity. Expression levels of Foxp3 mRNA in Nr4a2-induced Foxp3 +  
cells were one-quarter to one-third of that in restimulated Tregs   
(Fig. 4a). IL-2 was completely repressed, and CD25, a subunit of the 
high affinity Il-2 receptor complex, was higher than that in Tregs, 
suggesting that Nr4a2-induced Foxp3 +  cells can consume IL-2 by 
ligand–receptor interactions, similar to Tregs. Although TGF-β1 
and GITR were highly expressed in the Nr4a2-induced Foxp3 +  cells, 
IL-10 was repressed, and CTLA-4 required a long interval for induc-
tion. These data indicate that Nr4a2-induced Foxp3 +  cells expressed 
similar but distinctive set of Treg effectors.
Next, we performed an in vitro suppression assay to functionally 
characterize the Nr4a2-induced Foxp3 +  cells. The Nr4a2-induced 
Foxp3 +  cells in this assay efficiently suppressed the proliferation of 
TCR-stimulated naïve CD4 +  T cells (Fig. 4b). This strong in vitro 
suppression activity was mainly mediated by the IL-2 consump-
tion, which has been suggested to be a central mechanism for in 
vitro suppression by Tregs34, because supply of IL-2 in the medium   
significantly attenuated the suppression (Fig. 4b).
Nr4a2 induces iTregs and represses aberrant Th1 induction. The 
findings above suggest the involvement of Nr4a2 in Foxp3 induc-
tion and Th1 suppression. To analyse the roles of Nr4a2 in T-cell 
development  and  differentiation,  we  crossed  Nr4a2-floxed  mice 
with  Lck-Cre +   mice,  which  express  Cre-recombinase  specifically 
in  T  cells35,36.  Although  more  than  half  of  the  Nr4a2fl/flLck-Cre +  
mice died neonatally with unknown reasons, surviving mice deve-
loped normally and were fertile, and had no symptoms of auto-
immune diseases up to 4 months of age. However, the population 
of CD44highCD62Llow-activated CD4 +  T cells, as well as that of 
IFN-γ +  cells were significantly increased in Nr4a2fl/flLck-Cre +  mice 
compared with Nr4a2 + / + Lck-Cre +  littermates. On the other hand, 
the number of Tregs in the thymus and spleen was not altered in 
the Nr4a2fl/flLck-Cre +  mice (Supplementary Fig. S5a,b). We isolated 
naïve CD4 +  T cells from Nr4a2fl/flLck-Cre +  and Nr4a2 + / + Lck-Cre +  
mice, and cultured them under neutral, Th1-, Th17- and iTreg-
skewing conditions. We observed strong induction of Th1 under   
all culture conditions, and a decrease in iTreg and Th17 induc-
tion (Fig. 5a). Expression levels of Foxp3 protein were also lower 
in Nr4a2-deficient iTreg cells (Fig. 5b). These results are consistent 
with forced expression studies, which indicate the involvement of 
Nr4a2 in Th1 repression and Foxp3 induction.
As Nr4a2 is deleted early in T-cell development in the thymus 
of Nr4a2fl/flLck-Cre +  mice, these differences in CD4 +  T-cell differen-
tiation may merely reflect the altered nature of naïve T cells. To 
exclude this possibility, we used naïve CD4 +  T cells from Nr4a2fl/fl 
ERT2-Cre +  mice, in which the Nr4a2 alleles can be deleted ex vivo 
with tamoxifen (4-hydroxy tamoxifen) treatment. We confirmed 
the appropriate deletion of Nr4a2 with 6 h treatment with 4-hydroxy 
tamoxifen in vitro, specifically in Nr4a2fl/flERT2-Cre + CD4 +  T cells 
(Supplementary Fig. S5c). The results of the in vitro differentiation 
experiments were similar to those obtained with Lck-Cre (Fig. 5c–f), 
confirming that Nr4a2 in naïve T cells is necessary for iTreg induc-
tion and suppression of aberrant induction of Th1.
To evaluate the importance of the Nr4a2-mediated regulation of 
CD4 +  T-cell differentiation at pathological conditions in vivo, we 
analysed a mouse model of inflammatory bowel disease in Nr4a2fl/fl 
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Figure 2 | Nr4a2 induces Treg-like active histone modifications in Foxp3 
regulatory regions. (a–c) native ChIP assay of Foxp3 promoter (left), 
Cns1 (middle) and Cns2 (right) enhancers was performed with antibodies 
against modified histones (a: anti-acetylated H4, open bars; b: anti- 
tri-methylated H3K4, dotted bars; c: anti-tri-methylated H3K27, striped 
bars) and control IgG (filled bars). naïve T cells, Tregs, mock-transduced 
cultured cells and sorted GFP +  cells from the population of emIGR1 or 
emIGR1-nr4a2 retrovirus-transduced cells were analysed. Values are 
depicted as the percentage of corresponding input. Data are representative 
of two independent experiments (mean and s.d. of triplicate). (d) Bisulphite 
sequencing revealed that nr4a2 can not mediate the demethylation of 
the CpG island in the Cns2 region of the foxp3 locus. sequencing was 
performed against the bisulphite-treated genomic DnA from naïve T cells, 
Tregs, sorted GFP +  cells from the emIGR1 retrovirus-transduced cells and 
sorted GFP + Foxp3 +  cells from the emIGR1-nr4a2 retrovirus-transduced 
cells. Ten CG sites in the Cns2 locus, located at the indicated positions, 
were analysed. Top: closed and open circles indicate methylated and 
unmethylated CG sites, respectively. Bottom: data shown in top panels were 
quantitated, and shown as percentages of methylation at each position. 
Data are pooled from two independent experiments. Foxp3 +  cells were 
sorted with APC-conjugated anti-hCD2 antibody unless otherwise indicated.ARTICLE     
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Lck-Cre +  mice. Dextran sulphate sodium (DSS)-treatment signifi-
cantly accelerated body weight loss and induced severe intestinal 
inflammation in Nr4a2fl/flLck-Cre +  compared with Nr4a2 + / + Lck-Cre +  
mice (Fig. 5g,h). Furthermore, we observed a significant increase in 
the number of Th1 cells and the attenuated increase of Treg popula-
tion in colon and caecum lamina propria in Nr4a2fl/flLck-Cre +  mice 
treated with DSS (Fig. 5i,j). These data indicate that Nr4a2 is impor-
tant for Treg induction and suppression of aberrant Th1 induction, 
also at pathological conditions in vivo.
Nr4a2 is critical for sustained expression of Foxp3. Next, we ana-
lysed the roles of Nr4a2 in Tregs by breeding Nr4a2-floxed mice with 
Foxp3YFP-Cre mice36,37 to knockout Nr4a2 specifically in Tregs. We 
confirmed the specific deletion of Nr4a2 in Tregs (Supplementary 
Fig. S6a). Nr4a2fl/flFoxp3YFP-Cre mice were apparently normal, disease 
free and without differences in the activation status of CD4 +  T cells 
(Supplementary Fig. S6b). In the first experiment, we compared the 
relative sizes of Nr4a2-sufficient and Nr4a2-deficient Tregs popula-
tion  in  Nr4a2 + / + Foxp3YFP-Cre/ + ,  heterozygous  Nr4a2fl/ + Foxp3YFP-Cre/ +   
and homozygous Nr4a2fl/flFoxp3YFP-Cre/ +  females (foxp3 is on X chro-
mosome).  The  YFP + /YFP–  ratio  in  Nr4a2 + / + Foxp3YFP-Cre/ +   mice 
was near 1:1 in both thymus and periphery (Fig. 6a,b). However, 
in Nr4a2fl/flFoxp3YFP-Cre/ +  mice, ratios of YFP + /YFP −  were subopti-
mal (~0.3 in thymus and ~0.1 in periphery, Fig. 6a,b), indicating 
that Tregs were not properly maintained on deletion of Nr4a2. The   
YFP + /YFP −  ratio in Nr4a2fl/ + Foxp3YFP-Cre/ +  mice was near ~0.8 in 
thymus, and ~0.4 in periphery, indicating that Tregs are not properly 
maintained even by the heterozygous deletion of Nr4a2 (Fig. 6b).   
Importantly,  the  ratio  of  YFP + /YFP −   in  Nr4a2fl/flFoxp3YFP-Cre/ +   
mice decreased with age (Supplementary Fig. S6c), supporting the 
idea that the disequilibrium is caused by the accelerated reduction of 
the Nr4a2-deficient Tregs in the periphery, rather than the reduced 
positive selection of Tregs in the thymus. Another possibility which 
could explain this disequilibrium might be reduced export of Nr4a2-
deficient  Tregs,  although  we  think  it  less  probable,  because  the 
reduced export is expected to result in an increase in the number of 
Nr4a2-deficient Tregs in the thymus. Deletion of Nr4a1 did not affect 
the YFP + /YFP −  ratio in Tregs (Fig. 6a,b and Supplementary Fig. S6d), 
indicating that Nr4a1 does not contribute to Treg homoeostasis; this 
corresponds well with the observation that Nr4a1-transduction did 
not induce Foxp3 (Fig. 3a). The CpG methylation status of CNS2, an 
important determinant of Treg lineage stability, was not perturbed 
in  Nr4a2fl/flLck-Cre +   mice  (Supplementary  Fig.  S6e),  suggesting   
that Nr4a2 is not essential for the demethylation of CNS2 during 
nTreg development. This was consistent with our forced expression 
study (Fig. 2d).
The suboptimal YFP + /YFP −  ratio in Nr4a2-floxed Foxp3YFP-Cre/ +  
mice may be caused by the accelerated loss of Foxp3 expression, or 
by accelerated cell death or reduced proliferation. To examine these 
possibilities, we isolated CD4 + CD25 + YFP + Tregs from spleens and 
lymph nodes of Nr4a2fl/flFoxp3YFP-Cre and Nr4a2 + / + Foxp3YFP-Cre mice, 
cultured them in vitro and then monitored the Foxp3 expression. 
To exclude the contribution of cell death and expansion of Foxp3-
negative cells, we cultured the cells in the presence of thymidine and 
z-VAD-fmk to inhibit cell proliferation and apoptosis, respectively. 
We observed that the Nr4a2-deficient Tregs lost Foxp3 expression 
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with a significantly accelerated rate compared with Nr4a2-sufficient 
Tregs (Fig. 6c). As cell proliferation and death were properly inhib-
ited under this culture condition (Fig. 6d), the majority of Foxp3-
negative cells that appeared after culture were direct descendants of 
the Foxp3 +  Tregs. In addition, the Foxp3 positive fraction at 72 h of 
culture did not appear as sharp peaks, but as broader peaks with left 
‘shoulders’, suggesting the presence of Treg populations with ongo-
ing loss of Foxp3.
To further investigate the role of Nr4a2 in the maintenance of 
Foxp3 in Tregs, we co-transferred wild-type Ly5.1 + CD4 + CD25 + T
regs (~95% Foxp3 + ) and Nr4a2-deficeint Ly5.2 + CD4 + CD25 + YFP +  
Tregs (~99.7% Foxp3 + ) at 1:1 ratio into lymphopenic recipients.   
As previously reported, substantial fraction of Tregs became Foxp3-
negative after homoeostatic expansion24. After transfer, ~40% of the 
wild-type Ly5.1 +  Tregs became Foxp3-negative, whereas almost 80% 
of Ly5.1 −  fraction became Foxp3-negative (Fig. 6e, f). Importantly, 
although the level of Foxp3 protein expression was initially equiva-
lent, the Nr4a2-deficient Tregs exhibited a significantly lower level of 
Foxp3 than wild-type Tregs after transfer (Fig. 6f), strongly indicat-
ing the accelerated loss of Foxp3 in the Nr4a2-deficient Tregs. Alto-
gether, these results strongly suggest that Nr4a2 is directly involved 
in the Treg lineage maintenance by sustaining Foxp3 expression.
Nr4a2 cooperates with Runx/Cbfβ. The observed roles of Nr4a2 
in Foxp3 expression is reminiscent of that of Runx/CBFβ in Treg 
maintenance12,38. Through coimmunoprecipitation experiments on 
total cell lysates from primary CD4 +  T cells, we detected Runx1 in 
the anti-Nr4a2 immunoprecipitates, under Nr4a2-inducing condi-
tions (Fig. 6g). Considering the different capacities of the three Nr4a 
  proteins for Foxp3 induction and Treg maintenance, we compared 
the Nr4a’s binding affinity to Runx1. T7-tagged Nr4a and Flag-tagged 
Runx1 were ectopically expressed in 293T cells and the lysates were 
immunoprecipitated with anti-Flag antibodies. Nr4a2 showed the 
strongest affinity to Runx1 (Fig. 6h). We further investigated the 
functional interaction between Nr4a and Runx1 by reporter assay. 
We used a construct composed of the Foxp3 proximal promoter, 
which contains the Nr4a-responsive element identified in Fig. 1e, 
and CNS2, which reportedly contains Runx-responsive elements12 
(Fig. 6i). Although Runx1 itself could not activate this reporter, it 
enhanced Nr4a-mediated transactivation of the reporter (Fig. 6i). 
Importantly, the strongest synergistic effect occurred when Runx1 
interacted with Nr4a2. The result of the ChIP analysis in Figure 1f,   
which showed weak enrichment of the CNS2 in the anti-Nr4a2 
immunoprecipitates from Treg, further indicated the interaction 
between Nr4a2 on the promoter and Runx1 on CNS2 in Tregs. 
Overall, these results suggest that Nr4a2 and Runx/CBFβ cooper-
ates to maintain Treg lineage stability.
Nr4a2-deficient  Tregs  have  attenuated  suppressive  activity. 
To further investigate the roles of Nr4a2 in Tregs we measured   
expression levels of Treg markers, activation status, cell death and 
proliferation in YFP + Foxp3 +  and YFP–Foxp3 +  Tregs in Nr4a2 + / + 
 Foxp3YFP-Cre/ +  and Nr4a2fl/flFoxp3YFP-Cre/ +  mice, which allowed us to   
compare  Nr4a2-deficient  and  Nr4a2-suficient  Tregs  in  the  same 
mice. We observed decreased levels of Foxp3 and CD25 in YFP +  
fraction in Nr4a2fl/flFoxp3YFP-Cre/ +  mice (Fig. 7a). Other Treg markers 
such as CTLA-4 and GITR were expressed at a similar level between 
Nr4a2-deficient  and  Nr4a2-sufficient  Tregs  (Fig.  7a).  A  similar   
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expression pattern of CD62L indicated equivalent activation status. 
A similar percentage of cells staining positive for Annexin V and 
Ki67 indicated an equivalent rate of cell proliferation and death 
between  the  Nr4a2-deficient  and  Nr4a2-sufficient  Tregs,  further 
supporting the notion that the insufficiency of the Nr4a2-deficient 
Tregs observed in Figure 6a,b was not caused by a difference in cell 
death or proliferation. We also compared the expression levels of 
Treg-relevant mRNA between Tregs from Nr4a2 + / + Foxp3YFP-Cre and 
Nr4a2fl/flFoxp3YFP-Cre mice. We found decreased expression of Foxp3, 
indicating  that  the  accelerated  loss  of  Foxp3  in  Nr4a2-deficient 
Tregs was at the mRNA level (Fig. 7b). For other genes, we observed 
a significant reduction of CD25, TGF-β1 and CCR9.
Then we measured suppressive activity of Nr4a2-deficeint Tregs 
in vitro. Tregs from Nr4a2fl/flFoxp3YFP-Cre mice exhibited slightly, but 
significantly  less  suppressive  activity  compared  with  those  from 
Nr4a2 + / + Foxp3YFP-Cre mice (Fig. 7c), possibly caused by the lower 
expression of CD25 (refs 34, 39) and by the accelerated loss of 
Foxp3.
Finally, to assess the suppressive activity of the Nr4a2-deficient 
Tregs in vivo, we analysed the transfer model of colitis. We trans-
ferred wild-type naïve Ly5.1 + CD4 +  T cells alone or in combination 
with Ly5.2 + CD4 + CD25 + YFP + Tregs (~99.7% purity) from Nr4a2 + / + 
 Foxp3YFP-Cre  or  Nr4a2fl/flFoxp3YFP-Cre  mice,  into  Rag2-deficeint 
recipient. Within 10 days, body weight loss and severe intestinal 
  inflammation were found in recipients of naïve T cells, and this 
was prevented by Nr4a2-sufficient Treg (Fig. 7d and Supplementary   
Fig. S6f). In contrast, Nr4a2-deficient Tregs exhibited a significantly 
attenuated ability to inhibit the wasting disease and colitis (Fig. 7d 
and Supplementary Fig. S6f). We analysed the fate of transferred 
naïve T cells and Tregs according to Ly5.1 expression. We found a 
significant reduction in the Foxp3 +  population in Ly5.1 − CD4 +  frac-
tion  in  the  Nr4a2-deficeint  Treg-transferred  recipients,  whereas 
majority of the Nr4a2-sufficient Tregs still retain Foxp3 expression 
(Fig. 7e). In recipients with Nr4a2-deficeint Tregs, lamina proprial 
CD4 +  T cells contained fewer Ly5.1 −  cells, possibly caused by the 
lower  expression  of  CCR9,  a  gut-tropic  factor  of  lymphocytes40  
(Fig.  7b,e).  In  the  Ly5.1 − CD4 +   fraction  of  the  Nr4a2-deficeint 
Treg-transferred recipients, significant population of CD4 +  T cells 
expressed IFN-γ (Fig. 7e). These IFN-γ-positive CD4 +  were mainly 
Foxp3-negative, but some of the Foxp3-positive fraction was also 
IFN-γ +  (Fig. 7f). These data indicate that Nr4a2 is essential for both 
lineage maintenance and full-suppression activity of Tregs.
Discussion
We have demonstrated the strong ability of Nr4a2 to induce Foxp3 
and repress inflammatory cytokines, including IFN-γ thus regulat-
ing the Th1/Treg balance. Nr4a2 also has a role in mature Tregs 
by maintaining lineage stability and regulating effector molecules, 
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in g at day 11, examining IFn-γ and IL-17a expression (top) and Foxp3 expression (bottom). (j) Quantification of results in i. Data are representative of  
two independent experiments, each with five mice per group (mean ± s.d. of five mice). Filled bars: Nr4a2 + / + Lck-Cre +  mice; open bars: Nr4a2fl/flLck-Cre +  
mice. numbers in FACs plots represent percentages of CD4 +  T cells in the gated area. *P < 0.05, **P < 0.01 (two-tailed student’s t-test).ARTICLE
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including CD25 and TGF-β1. These roles are critical for maintain-
ing immune homoeostasis, as evidenced by the exacerbation of the 
model diseases as a result of Nr4a2 insufficiency.
To  the  best  of  our  knowledge,  no  previously  reported  factor 
induced Foxp3 as effectively as Nr4a2 expect for TGF-β. Given this 
ability for Foxp3 induction, and the induction of Nr4a2 by TCR 
stimulation, we speculate that Nr4a2 has a role in nTreg develop-
ment in the thymus. However, even in Nr4a2fl/flLck-Cre +  mice in 
which the Nr4a2 alleles were deleted during early T-cell develop-
ment before the Foxp3 induction, we observed the unperturbed 
development of nTreg. Although this result can be simply inter-
preted that Nr4a2 is not essential for nTreg induction, we suggest 
another possibility that, Nr4a3, which also exhibits Foxp3-inducing 
ability, redundantly acts to induce nTreg. In contrast, we observed   
a significant reduction in the number of Nr4a2-deficeint nTregs 
compared with Nr4a2-suffceint nTregs in the same mice (Fig. 6a). 
This discrepancy might be explained by compensatory homoeo-
static expansion of Tregs in Nr4a2fl/flLck-Cre +  mice. In contrast to 
the nTreg development, we observed significantly attenuated iTreg 
induction in vitro, with the aberrant induction of Th1. The exacer-
bation of colitis in DSS-treated Nr4a2fl/flLck-Cre +  mice provides evi-
dence for the importance of Th1/iTreg regulation by Nr4a2. In the 
regulation of Th1/iTreg differentiation, Nr4a2 directly induced Foxp3 
by activating the Foxp3 promoter/enhancer. Although the mecha-
nisms of IFN-γ repression by Nr4a2 are currently undiscovered, the 
Foxp3 induction and the IFN-γ repression might not be separable 
roles of Nr4a2, because Nr4a1, which could not induce Foxp3, also 
could not repress IFN-γ. Nr4a2 is expected to regulate expression 
of several genes in CD4 +  T cells. However, Foxp3 is an impor-
tant target, demonstrated by the production of Foxp3 +  Treg-like   
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suppressive cells by ectopic expression of Nr4a2, and by the signifi-
cant attenuation of iTreg induction and the impaired maintenance 
and function of Tregs by its deletion. Future studies comprehen-
sively analysing the target genes of Nr4a2 during Treg induction 
should facilitate our understanding if the molecular mechanisms of 
Th/iTreg regulation governed by Nr4a2.
The  clarification  of  the  mechanisms  underlying  Treg  lineage 
maintenance is particularly important, considering the recent active 
debate on Treg lineage stability. It was recently reported that Tregs are 
mainly composed of a stable population41. Our study suggests that the 
high level of Nr4a2 contributes to the lineage stability. The importance 
of Nr4a2 in terms of Treg maintenance can be further speculated 
from our observation that Nr4a2 was not expressed in the in vitro-
induced iTreg, which is an unstable cell population42,43. Although the 
trials to develop stable iTregs, aimed at the treatment of autoimmune 
diseases, allergies and successful organ transplantation seem to focus 
on the demethylation of CNS2 (refs 43–45), maintaining a sufficient 
level of Nr4a2 should also contribute to iTreg stability.
Runx/CBFβ  is  necessary  for  maintaining  Treg  functions12,38. 
In this study, we observed the physical and functional interaction 
between Runx1 and Nr4a2. Although Runx1 alone directly upregu-
lates IFN-γ, it represses the gene in the presence of Foxp3 (ref. 46). 
This  result  corresponds  well  with  our  observations  that  Nr4a2 
represses IFN-γ and that this repression was further strengthened 
by Foxp3 expression. It is possible that Nr4a2 forms a ternary com-
plex with Runx1 and Foxp3, thereby stabilizing Tregs. This phe-
nomenon also supports the hypothesis that Foxp3 and IFN-γ are 
not totally separable targets of Nr4a2, but instead components of an 
auto-regulatory system driven by Nr4a2 and Foxp3, leading to tight 
repression of IFN-γ, which effectively sustains Tregs cell lineage. In 
addition to Runx/CBFβ, Nr4a2 may work with other foxp3-regula-
tors (Smads, c-Rel, Stat5 and so on), for Foxp3 induction in CD4 +  
T cells, because the ectopic expressions of Nr4a2 in other cell types 
induce distinct subsets of genes, which apparently do not contain 
Foxp3 (refs 18, 47).
We observed significant attenuation of the suppressive activity 
of Nr4a2-deficient Tregs in the transfer model of colitis in Rag2–/–  
mice.  However,  the  Nr4a2fl/flFoxp3YFP-Cre  mice  did  not  show  any 
inflammatory or autoimmune diseases. In the Nr4a2fl/flFoxp3YFP-Cre 
mice, we speculate that Tregs in the lymphoid organs and intestine 
2.67
2.88
2.37
2.24
14.5
14.1
14.1
12.6
YFP+Foxp3+
YFP–Foxp3+
Foxp3–
Nr4a2 +/+
Foxp3 Yfp-Cre/+
Nr4a2 fl/fl
Foxp3 Yfp-Cre/+
Foxp3 CD25 CD62L CTLA-4 GITR AnnexinV
Ki67
C
e
l
l
 
n
u
m
b
e
r
100101102103104
0
20
40
60
80
100
0
1
2
3
4 * *
0
1
2
3
0
1
2
3
0
1
2
3
4
0
0.1
0.2
0.3
0.4
0
0.005
0.01
0.015
0.001
0.002
0.003
0.004
0.005
0 0
0.5
1
1.5
2
0
1
2
3
0
0.5
1
1.5
2
0
0.5
1
1.5
0
0.1
0.2
0.3
0.4
0.5
CFSE
E
v
e
n
t
s
Responder
only
+ Nr4a2+/+
Treg 1:1
+ Nr4a2∆/∆
Treg 1:1
64.8 8.14 21.9
C
e
l
l
s
 
w
i
t
h
 
>
3
 
 
d
i
v
i
s
i
o
n
 
(
%
)
Tresp 1:8 1:3 1:1
0
20
40
60
80
*
Treg:Tresp
100101102103104
100
101
102
103
104
100101102103104
0
200
400
600
800
0
200
100
150
50
0
200
100
150
50
R
e
l
a
t
i
v
e
 
b
o
d
y
 
w
e
i
g
h
t
0.6
0.8
1
1.2
0 7 14 21
Days
Spl+LN Colon+caecum LPL f
Tnaive
only
Tnaive
+ Nr4a2+/+
Treg
Tnaive
+ Nr4a2∆/∆
Treg
F
o
x
p
3
Ly5.1
F
o
x
p
3
I
F
N
-
γ
I
F
N
-
γ
0 0.97
0.025 99
29.6 0.64
6.66 63.1
0.54
29.4 56.8
13.3
0 1.38
0.034 98.6
19.6 0.51
12.8 67.1
0.82
16.2 78.5
4.48
F
o
x
p
3
IFN-γ
0.03 5.71
0.28 94
4.55
39.5 54
2 39.3
12.4 36.9
11.4
69.1
0.071 30.8
0
Gated on
Ly5.1– CD4+
Gated on
Ly5.1+ CD4+
0.55
63 5.28
31.2
0.019
91.3 7.84
0.81
18.9
27.2 50.1
3.8 1.88
35.5 62.3
0.37
Tnaive+
Nr4a2∆/∆Treg
F
o
x
p
3
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
C
d
2
5
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
C
t
l
a
4
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
G
i
t
r
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
I
f
n
g
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
I
L
1
7
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
I
L
2
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
I
L
1
0
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
T
g
f
b
1
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
T
g
f
b
r
1
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
T
g
f
b
r
2
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
C
c
r
9
 
e
x
p
r
e
s
s
i
o
n
(
r
e
l
a
t
i
v
e
)
*
*
100
101
102
103
104
100101102103104
Figure 7 | Attenuated in vitro and in vivo suppressive activity of Nr4a2-deficient Tregs. (a) FACs analysis of the indicated protein levels in YFP + Foxp3 +  
and YFP–Foxp3 +  Tregs of Nr4a2 + / + Foxp3Yfp-Cre/ +  or Nr4a2fl/flFoxp3Yfp-Cre/ +  mice. For Foxp3, CD25, CTLA-4 and GITR expression levels in non-Treg cells are 
represented by black lines, as a negative value. Data are representative of three independent experiments (means of duplicate are shown for the positive 
fractions of Annexin V and Ki67 staining). (b) Comparison of mRnA levels between Tregs in Nr4a2 + / + Foxp3Yfp-Cre and Nr4a2fl/flFoxp3Yfp-Cre mice. Expression 
levels of the indicated mRnA, are presented relative to Hprt expression. open bars: Nr4a2 + / + Foxp3Yfp-Cre Tregs; closed bars: Nr4a2fl/flFoxp3Yfp-Cre Tregs. (c) 
Top: in vitro suppression assay with CFsE-labeled wild-type CD4 + CD25– cells as responders and CD4 + CD25 + YFP +  Tregs from Nr4a2 + / + Foxp3Yfp-Cre (open 
squares) or Nr4a2fl/flFoxp3Yfp-Cre (closed triangles) mice as suppressors. Ratios of responder cells with more than three divisions are presented. Bottom: 
results in the top panel at 1:1 Treg/Tresp ratio. (d) Body weight of Rag2– mice injected with 5×105 naïve Ly5.1 + CD4 +  T cells alone or in combination with 
3×105 CD4 + CD25 + YFP + Ly5.2 +  Tregs from Nr4a2 + / + Foxp3Yfp-Cre or Nr4a2fl/flFoxp3Yfp-Cre mice. Data are pooled from two independent experiments, with 
seven mice from each sample set total. The ranges of body weights (relative body weights to day 0) of each group at day 21 are Tnaive only: 0.69–0.76; 
Tnaive + Nr4a2 + / + Foxp3Yfp-Cre Tregs: 0.96–1.08; Tnaive + Nr4a2fl/flFoxp3Yfp-Cre Tregs: 0.76–0.88. (e) Expression of Foxp3 and IFn-γ in CD4 +  T cells from  
the spleen and lymph nodes (left panels), and from the colon and caecum lamina propria (right panels) in Rag2– recipients presented in d at day 21.  
(f) Frequencies of IFn-γ-expressing cells in Foxp3–CD4 +  T cells and Foxp3 + CD4 +  T cells from the spleen and lymph nodes of Rag2– recipients presented 
in d at day 21. numbers in FACs plots represent percentages of CD4 +  T cells in the gated area. Data in b, c are representative of three independent 
experiments (mean and s.d. of triplicate). *P < 0.05 (two-tailed student’s t-test).ARTICLE
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were maintained in normal number by homoeostatic maintenance 
under the specific pathogen-free condition. However, the abnor-
malities of the Nr4a2-deficient Tregs might be highlighted in the 
transfer model of colitis, an acute inflammatory disorder condition, 
with accelerated loss of Foxp3 during homoeostatic expansion in 
lymphopenic mice24,40, and the suboptimal homing of Nr4a2-defi-
ceint Tregs to intestine after intravenous injection, due to the lower 
CCR9 levels. From the in vitro and in vivo suppression assays, it is 
indicated that Nr4a2 is also involved in the suppressive functions of 
Tregs by regulating effector expression. CD25 and TGF-β1 might be 
directly regulated by Nr4a2, because the ectopic expression of Nr4a2 
upregulated both molecules, and the deletion of Nr4a2 resulted in 
their reduction.
In conclusion, we propose that Nr4a2 be added to the list of Treg 
regulators, on account of the strong induction of Foxp3 and the   
suppressive activity by ectopic Nr4a2 in CD4 +  T cells, the aberrant 
Th1/Treg differentiation of Nr4a2-deficient CD4 +  T cells and the per-
turbed lineage maintenance of Nr4a2-deficient Tregs. The ability of 
Nr4a2 to induce Foxp3 even under Th1 or Th17 conditions, together 
with its ability to impart suppressive activity to CD4 +  T cells, make it 
a potential therapeutic target for inflammatory diseases.
Methods
Mice. All work performed using mice was carried out in accordance with the 
guidelines for animal care approved by Keio University. Animals were maintained 
in specific pathogen-free conditions. Foxp3-hCD2-hCD52-KI mice24 were originally 
from the laboratory of Dr S Hori. The Nr4a1-floxed and Nr4a2-floxed mice from 
Dr H Ichinose have been described elsewhere36. Foxp3YFP-Cre knock-in mice were 
provided by Dr A Rudensky37. All mouse studies have been performed regardless of 
their sex, except for those for the epigenetic analysis of foxp3 locus, in which male 
mice were used. We did not obtain different results between males and females in 
our studies.
Antibodies. The monoclonal antibody against Nr4a1 (H1648) and Nr4a2 (N1404) 
was purchased from Perseus Proteomics. Antibodies to actin (A2066) and Flag-tag 
(M2) were purchased from Sigma. Anti-T7-tag polyclonal antibody (PM022) was 
purchased from MBL. Phycocerythrin-, PerCP-Cy5.5-, allophycocyanin (APC)- 
and APC-Cy7-conjugated monoclonal antibodies for CD4 (L3T4), CD8 (53-6.7), 
hCD2 (LFA-2), Foxp3 (FJK-16s), IFN-γ (KMG1.2), IL-2 (JES6-5H4), IL-10 
(JES5-16E3) and IL-17a (eBio17B7) antibodies were purchased from eBiosciences. 
Anti-Runx1 antibody was purchased from Active Motif. PerCP-Cy5.5-conjugated 
anti-mouse Ki67 goat polyclonal antibody (M-19) was purchased from Santa Cruz. 
Annexin V staining was performed with Annexin V-Biotin Apoptosis Detection 
Kit (BioVision).
Isolation of naïve T cells and Tregs. For thymic CD4-SP, CD25– T-cell prepara-
tion, thymocytes from 6- to 8-week-old mice were depleted of non-CD4-SP T cells 
by the application of biotin-conjugated antibodies against CD8a, B220, CD25, 
CD11b, CD49b, TER-119 and hCD2, at concentrations of 1 µg per 107 cells in com-
bination with streptavidin microbeads, using large depletion columns (Miltenyi). 
CD4-SP cells were further purified with anti-CD4 magnetic beads using medium 
separation columns (Miltenyi). The purity of CD4-SP CD25 − Foxp3 −  T cells was 
consistently greater than 95%. For naïve CD4 +  T-cell (CD4 + CD25–CD62Lhi) 
preparation from the spleen and lymph nodes, spleen and lymph node cells from 
6- to 8-week-old mice were depleted of non-CD4 + T cells by the application of 
biotin-conjugated antibodies against CD8a, B220, CD25, CD11b, CD49b, TER-119 
and hCD2, at concentrations of 1 µg per 107 cells in combination with streptavidin 
microbeads, using large depletion columns (Miltenyi). Then, cells were incubated 
with biotin-conjugated antibodies against CD62L, followed by incubation with 
streptavidin microbeads, and the CD62hi cells were positively selected using large 
selection columns (Miltenyi). For Treg preparation, the spleen and lymph node 
cells were labelled with anti-CD4, anti-CD25 and anti-hCD2 (when using the 
Foxp3-hCD2-hCD52-KI mice) at a concentration of 0.5 µg ml − 1 or YFP-fluores-
cence (when using the Foxp3YFP-Cre mice) and triple-positive cells were sorted using 
a FACSAria.
Culture of primary T cells. Cells were cultured under neutral conditions (plate-
coated anti-CD3e (2C11, 2 µg ml − 1) and anti-CD28 (57.31, 0.5 µg ml − 1) antibodies, 
IL-2 (PeproTech, 5 ng ml − 1), 2-Mercaptoethanol (Invitrogen, 55 µM), and 10% fetal 
bovine serum in RPMI1640 unless otherwise indicated. For Th-skewing condi-
tions, cells were cultured in RPMI1640 medium supplemented with plate-coated 
anti-CD3e (2C11, 2 µg ml − 1), anti-CD28 (57.31, 0.5 µg ml − 1), 2-Mercaptoethanol 
(Invitrogen, 55 µM) and 10% fetal bovine serum, supplemented with the following:  
for iTreg: anti-IFN-γ (R4-6A2, 1 µg ml − 1), anti-IL-4 (1 µg ml − 1)) antibodies, 
5 ng ml − 1 IL-2 and recombinant human TGF-β (2 ng ml − 1, R&D Systems); for Th1: 
anti-IL-4 (1 µg ml − 1), 5 ng ml − 1 IL-2, IL-12 (PeproTech, 10 ng ml − 1); for Th2: anti-
IFN-γ (R4-6A2, 1 µg ml − 1), 5 ng ml − 1 IL-2, IL-4 (PeproTech, 10 ng ml − 1); and for 
Th17: anti-IFN-γ (1 µg ml − 1), anti-IL-4 (1 µg ml − 1) antibodies, human IL-6 (R&D 
Systems, 10 ng ml − 1), and recombinant human TGF-β1 (1 ng ml − 1 R&D Systems).
Protein analysis. For immunoprecipitation, cells were lysed in lysis buffer 
(140 mM NaCl, 1% Triton X-100, 1 mM EDTA, 10 mM Tris (pH 8.0), supple-
mented with protease inhibitor cocktail (Nacalai Tesque)) for 1 h at 4 °C. Cell 
lysates were incubated with 1 µg of the appropriate antibodies for 4 h at 4 °C, then 
incubated with 15 µl protein G-Sepharose (GE Healthcare). Immunoprecipitates 
were washed five times with wash buffer (140 mM NaCl, 0.1% Triton X-100, 1 mM 
EDTA, 10 mM Tris (pH 8.0)). Proteins were dissolved in SDS–polyacrylamide gel 
electrophoresis sample buffer, then separated by SDS–polyacrylamide gel electro-
phoresis and electrotransferred to an Immobilon-P PDVF membrane (Millipore). 
Membranes were hybridized with the indicated antibodies at a concentration of 
1 µg ml − 1, then visualized using an ECL-Plus detection system (GE Healthcare).
mRNA preparation and quantitative PCR. Total RNA was extracted using an 
RNeasy Micro Kit (Macherey Nagel) and subjected to reverse transcription using 
a High Capacity cDNA Synthesis Kit (Applied Biosystems). PCR analysis was 
performed with an iCycler iQ multicolor real-time PCR detection system (Bio-
Rad) and a KAPA SYBR FAST qPCR Kit (Kapa Biosystems). All primer sets yielded 
a single product of the correct size. Relative expression levels were normalized 
against Hprt.
Crosslinked chromatin immunoprecipitation. Crosslinked chromatin immuno-
precipitation were performed as follows; total cells from spleens and lymph nodes 
from three male mice were stained with phycocerythrin-conjugated anti-CD25 
and PerCP-conjugated anti-CD4 antibodies before fixation, at 1 µg ml − 1. Cells 
were then fixed with 10 ml of 1% formaldehyde for 15 min with occasional swirl-
ing. Crosslinking was stopped by adding glycine to 125 mM. Cells were washed 
three times in PBS and dissolved in FACS buffer; afterward, CD4 + CD25 −  and 
CD4 + CD25 +  populations from male mice were sorted using a FACSAria cell sorter. 
Collected cells were lysed in 200 µl of a solution consisting of 20 mM Tris (pH 7.5), 
5 mM EDTA and 0.5% SDS, supplemented with a protease inhibitor cocktail for 
10 min while rotating at 4 °C. Genomic fragments were sonicated to a mean size 
of ~400 bp. After insoluble material was removed through centrifugation, 50 µl of 
the supernatants was used as input, and the remainder was diluted fivefold in 1% 
Triton X-100, 2 mM EDTA, 150 mM NaCl and 20 mM Tris (pH 8.0) with a protease 
inhibitor cocktail. Immunoprecipitation was induced with 1 µg of anti-Nr4a2mAb 
or control mouse IgG overnight at 4 °C. Complexes were recovered by incubation 
with 20 µl of protein A agarose/Salmon Sperm DNA (Millipore) for 2 h at 4 °C. 
Precipitates were washed serially with 1 ml of RIPA buffer (50 mM Tris (pH 8.0), 
150 mM NaCl, 0.1% SDS, 0.5% Na-deoxycholate, 1% NP-40, 1 mM EDTA), 1 ml of 
50 mM Tris (pH 8.0), 500 mM NaCl, 0.1% SDS, 0.5% Na-deoxycholate, 1% NP-40, 
1 mM EDTA, 1 ml of 50 mM Tris (pH 8.0), 1 mM EDTA, 250 mM LiCl, 1% NP-40 
and 0.5% Na-deoxycholate, and then twice with 1 ml of TE. Chromatin samples 
were removed from the beads twice with 100 µl of 1% SDS and 0.1 M NaHCO3 
for 30 min at room temperature with constant agitation. After centrifugation, 
supernatants were treated with 0.2 mg ml − 1 RNaseA for 30 min at room tempera-
ture, then with 0.2 mg ml − 1 proteinase K for 5 h at 56 °C. Crosslinking was reversed 
by overnight incubation at 65 °C. After phenol–chloroform extraction, the aqueous 
phase was ethanol-precipitated and dissolved with 100 µl of TE buffer. Products 
were analysed by quantitative PCR. The PCR primer sets used are listed below.
Isolation of lamina propria leucocytes. Colons with caecums were excised and 
laced in ice-cold PBS. After washing out the luminal contents with PBS, colons and 
caecums were longitudinally opened, minced into ~0.5 cm pieces and incubated in 
Ca- and Mg-free Hank’s buffered salt solution containing 2% fetal bovine serum 
(FBS) and 1 mM EDTA for 45 min at 37 °C with constant agitation, to release intes-
tinal epithelial cells. The remaining tissues were further minced into ~1 mm pieces, 
and were digested with 0.5 mg ml − 1 Collagenase D (Roche) and 0.3 mg ml − 1 DNaseI 
in RPMI1640 10% FBS, for 1 h at 37 °C with constant agitation. Lamina propria 
lymphocytes (LPLs) were purified on a 37%/75% Percoll (GE Healthcare) gradient 
by centrifugation for 20 min at 25 °C at 600 g with no break.
Transfer model of colitis. Naïve CD4 +  T cells (CD4 + CD25–CD62Lhi; 5×105) 
alone or in combination with 3×105 Treg (CD4 + CD25 + YFP + Ly5.2 + ) cells from 
Nr4a2 + / + Foxp3Yfp-Cre or Nr4a2fl/flFoxp3Yfp-Cre mice were intravenously injected into 
Rag2–/– recipient mice. Transferred mice were monitored daily for weight loss.  
At day 21 post-transfer, animals were sacrificed for analysis.
DSS-induced colitis. Mice were given 1.5% DSS (mw 36,000–50,000;  
MP Biomedicals) dissolved in drinking water for 8 days, followed by the provision 
of normal drinking water for 3 days. Mice were monitored daily for weight loss.
Bisulphite sequencing. Genomic DNA extracted from ~2×105 cells from male 
mice were digested with BamHI. H2O was added to the 500 ng of the digested DNA 
to a volume of 19 µl, and 1.2 µl of 6 N NaOH was then added; the mixture was then 
incubated at 37 °C for 15 min. Next, 120 µl of 3.6 N sodium bisulphite, 0.57 mM ARTICLE     
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hydroquinone and 0.3 N NaOH were added. Samples were then treated with 15 
cycles of 95 °C for 30 s to 50 °C for 15 min. The reaction was then desalted using 
the Wizard DNA Clean-up System (Promega), and eluted with 50 µl of TE. Three 
microliters of 5 N NaOH were added and the samples were incubated for 5 min at 
room temperature. The products were then ethanol-precipitated and dissolved with 
50 µl of TE buffer. The CNS2 region was PCR amplified with the primer set shown 
in supplemental materials and methods, and T/A cloned into pGEM-T Easy Vector 
(Promega). Ten inserted plasmids from each condition were purified and sequenced.
In vitro suppression assay. Responder cells (CD4 + CD25–CD62Lhigh; 2×104) were 
labelled with 5 µM carboxyfluorescein diacetate succinimidyl diester (CFSE, Invit-
rogen), then cultured together with unlabelled cells at the indicated ratio for 96 h at 
37 °C in 200 µl of RPMI medium plus 10% FBS, supplemented with 55 µM β-mer-
captoethanol, in the presence of Dynabeads Mouse T-activator CD3/CD28 (Veritas) 
in round-bottomed 96-well dishes at a concentration of 1 bead per cell. CFSE dilu-
tion was analysed by flow cytometry, after quenching GFP fluorescence by fixation 
and permeabilization with a Foxp3 Staining Kit (eBioscience), if necessary. 
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